John Edvard Karlsrud • 1974 • Oslo • 5 roles • 10 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
D DAEDALUS AS	Managing Director/CEO	-	6,752,413	100 % directly

Boards

Name	Role	Total operating income	Total equity	Shares
D DAEDALUS AS	Chairman	-	6,752,413	100 % directly
O ONCOSYNE AS	Board Member	1,656,989	5,197,039	4.57 % indirectly
F FORTRESS FUND 1 AS	Board Member	-	11,816,120	1.81 % indirectly
D DUGNAD	Board Member	-	-	-

Last update: Apr 13, 2023

Related industries3

Professional, scientific and technical activities
Financial and insurance activities
Human health and social work activities

Direct relationships5

JM
Janne Merethe Nestvold1963
ONCOSYNE AS
BT
Bengt Thomas Andersson1952
ONCOSYNE AS
ØS
Øyvind Sverre Bruland1952
ONCOSYNE AS
SW
Svenn Widerberg1948
ONCOSYNE AS
PA
Peter Andreas Wold Eide1982
ONCOSYNE AS

Shares owned by John Edvard Karlsrud

Name	Share class	Total operating income	Total equity	Share
D DAEDALUS AS	Ordinære aksjer	0	6,752,413	100 % directly
T TILT AS	Ordinære aksjer	27,397,766	4,419,156	19.44 % directly
B BLT SALONGER AS		0	-41,590	19.44 % indirectly
B BADSTUGATA VEDLIKEHOLD AS		840,000	-44,904	19.44 % indirectly
N NEOTILT AS		0	2,841	19.44 % indirectly
O ONCOSYNE AS		1,656,989	5,197,039	4.57 % indirectly
F FORTRESS FUND 1 AS		0	11,816,120	1.81 % indirectly
E EYR MEDICAL AS		27,052,579	41,242,764	0.82 % indirectly
V VIKING VENTURE 27 AS		0	123,697,193	0.69 % indirectly
Z ZAPTEC ASA	NO0010713936	0	740,958,000	0.04 % directly < 0.01 %

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024